• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多年来良性前列腺增生手术的趋势:一项多中心14年回顾性研究。

Trends in benign prostatic hyperplasia surgery over the years: A multicenter 14-year retrospective study.

作者信息

İbis Muhammed Arif, Cayan Selahittin, Tokatli Zafer, Orhan İrfan, Ascı Ramazan, Kocamanoglu Fatih, Akbay Erdem, Yaman Onder

机构信息

Department of Urology, University of Health Sciences, Keçiören Training and Research Hospital, Ankara, Turkey.

Department of Urology, Mersin University School of Medicine, Mersin, Turkey.

出版信息

Turk J Urol. 2021 Nov;47(6):501-508. doi: 10.5152/tud.2021.21262.

DOI:10.5152/tud.2021.21262
PMID:35118969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9612752/
Abstract

OBJECTIVE

The aim of this study is to show the surgical trend over the past 14 years using the data from five major centers in Turkey with accumulated experience in benign prostatic hyperplasia (BPH) surgery.

MATERIAL AND METHODS

This study included 94,954 patients with low urinary tract symptoms (LUTSs) secondary to BPH. By using electronic databases, we identified 7,163 patients who underwent BPH surgery, including monopolar transurethral prostate resection (M-TURP), bipolar transurethral prostate resection (BTURP), transurethral incision of the prostate (TUIP), open prostatectomy (OP), and holmium laser enucleation of the prostate (HoLEP) from 2006 to 2019. The years were grouped as 2006-2010, 2011-2015, and 2016-2019.

RESULTS

The total number of outpatient treatments for BPH increased by 72.9% from 5,379 in 2006 to 9,302 in 2019. Until 2019, the annual number of surgeries increased from 375 to 937 (increasing 150%). All surgical approaches for BPH, except TUIP, were most frequently performed between the ages of 60 and 69. The rate of surgery including M-TURP, B-TURP, and TUIP was statistically different between 2006 and 2010, 2011 and 2015, and 2016 and 2019 (P < .001), except OP (P ¼ .071). The highest increase was observed in HoLEP in the first half of the 2010s compared to the second half of the 2010s. The rate of M-TURP decreased from 77.9% to 17.9% from 2016 to 2019.

CONCLUSION

With the aging population, the number of patients diagnosed and treated with BPH is increasing. B-TURP as a resection technique and HoLEP as an enucleation technique replace M-TURP. Healthcare services and government spending should be organized according to these data.

摘要

目的

本研究旨在利用土耳其五个主要中心积累的良性前列腺增生(BPH)手术经验数据,展示过去14年的手术趋势。

材料与方法

本研究纳入了94954例继发于BPH的下尿路症状(LUTS)患者。通过电子数据库,我们确定了2006年至2019年期间接受BPH手术的7163例患者,包括单极经尿道前列腺切除术(M-TURP)、双极经尿道前列腺切除术(BTURP)、经尿道前列腺切开术(TUIP)、开放性前列腺切除术(OP)和钬激光前列腺剜除术(HoLEP)。年份分为2006 - 2010年、2011 - 2015年和2016 - 2019年。

结果

BPH门诊治疗总数从2006年的5379例增加到2019年的9302例,增长了72.9%。到2019年,手术年数从375例增加到937例(增长150%)。除TUIP外,所有BPH手术方式最常发生在60至69岁之间。2006年与2010年、2011年与2015年以及2016年与2019年之间,包括M-TURP、B-TURP和TUIP在内的手术率在统计学上存在差异(P <.001),OP除外(P = 0.071)。与2010年代后半期相比,2010年代前半期HoLEP的增长幅度最大。2016年至2019年,M-TURP的比例从77.9%降至17.9%。

结论

随着人口老龄化,诊断和治疗BPH的患者数量在增加。作为一种切除技术的B-TURP和作为一种剜除技术的HoLEP正在取代M-TURP。应根据这些数据来组织医疗服务和政府支出。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e03/9612752/00e3c8f8c362/tju-47-6-501-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e03/9612752/d9af57558b08/tju-47-6-501-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e03/9612752/97b840d6e3f6/tju-47-6-501-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e03/9612752/0dd7383427c5/tju-47-6-501-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e03/9612752/b3b1fdfaa59f/tju-47-6-501-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e03/9612752/00e3c8f8c362/tju-47-6-501-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e03/9612752/d9af57558b08/tju-47-6-501-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e03/9612752/97b840d6e3f6/tju-47-6-501-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e03/9612752/0dd7383427c5/tju-47-6-501-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e03/9612752/b3b1fdfaa59f/tju-47-6-501-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e03/9612752/00e3c8f8c362/tju-47-6-501-g005.jpg

相似文献

1
Trends in benign prostatic hyperplasia surgery over the years: A multicenter 14-year retrospective study.多年来良性前列腺增生手术的趋势:一项多中心14年回顾性研究。
Turk J Urol. 2021 Nov;47(6):501-508. doi: 10.5152/tud.2021.21262.
2
Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).钬激光前列腺剜除术(HoLEP)治疗复发性/残留良性前列腺增生(BPH)的可行性。
BJU Int. 2012 Dec;110(11 Pt C):E845-50. doi: 10.1111/j.1464-410X.2012.11290.x. Epub 2012 Jun 15.
3
Benign Prostatic Hyperplasia Endoscopic Surgical Procedures in Kidney Transplant Recipients: A Comparison Between Holmium Laser Enucleation of the Prostate, GreenLight Photoselective Vaporization of the Prostate, and Transurethral Resection of the Prostate.肾移植受者良性前列腺增生的内镜手术治疗:钬激光前列腺剜除术、绿激光前列腺汽化术和经尿道前列腺电切术的比较。
J Endourol. 2020 Feb;34(2):184-191. doi: 10.1089/end.2019.0430. Epub 2019 Nov 8.
4
The diagnostic value of prostate cancer between holmium laser enucleation of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia: A retrospective comparative study.钬激光前列腺剜除术与经尿道前列腺电切术治疗良性前列腺增生的前列腺癌诊断价值:一项回顾性对比研究。
Int J Surg. 2020 Jul;79:217-221. doi: 10.1016/j.ijsu.2020.05.025. Epub 2020 May 21.
5
[Transurethral resection of the prostate versus transurethral holmium laser enucleation of the prostate for benign prostatic hyperplasia with bladder detrusor overactivity].经尿道前列腺切除术与经尿道钬激光剜除术治疗合并膀胱逼尿肌过度活动症的良性前列腺增生症的对比研究
Zhonghua Nan Ke Xue. 2016 Aug;22(8):720-724.
6
Benign Prostatic Hyperplasia Surgery: A Snapshot of Trends, Costs, and Surgical Retreatment Rates in the USA.良性前列腺增生症手术:美国的趋势、成本和再次手术率的快照。
Eur Urol Focus. 2024 Sep;10(5):826-832. doi: 10.1016/j.euf.2024.04.006. Epub 2024 Apr 25.
7
Perioperative and economic analysis of surgical treatments for benign prostatic hyperplasia: A study of the French committee on LUT.良性前列腺增生手术治疗的围手术期及经济学分析:法国下尿路症状委员会的一项研究
Prog Urol. 2017 May;27(6):362-368. doi: 10.1016/j.purol.2017.03.010. Epub 2017 May 8.
8
A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).一项随机试验,比较钬激光前列腺剜除术与经尿道前列腺切除术治疗大腺体(40至200克)良性前列腺增生继发膀胱出口梗阻的疗效。
J Urol. 2003 Oct;170(4 Pt 1):1270-4. doi: 10.1097/01.ju.0000086948.55973.00.
9
Trends and attitudes in surgical management of benign prostatic hyperplasia.良性前列腺增生症手术治疗的趋势与态度
Can J Urol. 2012 Apr;19(2):6170-5.
10
Clinical outcome of transurethral enucleation of the prostate using the 120-W thulium Laser (Vela™ XL) compared to bipolar transurethral resection of the prostate (TURP) in aging male.经尿道钬激光前列腺剜除术(120-W 钬激光,VelaXL)与双极经尿道前列腺切除术(TURP)治疗老年男性前列腺增生的临床疗效比较。
Aging (Albany NY). 2020 Jan 28;12(2):1888-1898. doi: 10.18632/aging.102720.

引用本文的文献

1
A critical evaluation of Optilume BPH as a novel minimally invasive surgical treatment for the management of lower urinary tract symptoms in men.对Optilume BPH作为一种用于治疗男性下尿路症状的新型微创手术疗法的批判性评估。
Transl Androl Urol. 2024 Apr 30;13(4):653-656. doi: 10.21037/tau-23-578. Epub 2024 Apr 11.
2
Persistent Lower Urinary Tract Symptoms After BPH Surgery.良性前列腺增生术后持续下尿路症状
Curr Urol Rep. 2024 Jun;25(6):125-131. doi: 10.1007/s11934-024-01202-y. Epub 2024 Apr 5.

本文引用的文献

1
Assessing the Outcome of Holmium Laser Enucleation of the Prostate by Age, Prostate Volume, and a History of Blood Thinning Agents: Report from a Single-Center Series of >1800 Consecutive Cases.评估年龄、前列腺体积和使用血液稀释剂对钬激光前列腺剜除术结局的影响:来自单一中心 >1800 例连续病例的报告。
J Endourol. 2021 May;35(5):639-646. doi: 10.1089/end.2020.0605. Epub 2021 Jan 29.
2
Holmium laser enucleation of the prostate for the treatment of size-independent BPH: A single-center experience of 600 cases.钬激光前列腺剜除术治疗与大小无关的良性前列腺增生症:单中心600例经验。
Turk J Urol. 2020 Jan 17;46(3):219-225. doi: 10.5152/tud.2020.19235. Print 2020 May.
3
Trends in Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia, 2004 to 2013: the Urologic Diseases in America Project.
2004 年至 2013 年与良性前列腺增生相关的下尿路症状趋势:美国泌尿学疾病项目。
J Urol. 2020 Jan;203(1):171-178. doi: 10.1097/JU.0000000000000499. Epub 2019 Aug 20.
4
Analysis of Present Status for Surgery of Benign Prostatic Hyperplasia in Korea Using Nationwide Healthcare System Data.利用全国医疗保健系统数据对韩国良性前列腺增生症手术现状的分析。
Int Neurourol J. 2019 Mar;23(1):22-29. doi: 10.5213/inj.1836198.099. Epub 2019 Mar 31.
5
National trends in surgical therapy for benign prostatic hyperplasia in Australia.澳大利亚良性前列腺增生手术治疗的全国趋势。
ANZ J Surg. 2019 Apr;89(4):345-349. doi: 10.1111/ans.15016. Epub 2019 Feb 1.
6
Assessing the Learning Curve of Holmium Laser Enucleation of Prostate (HoLEP). A Systematic Review.评估钬激光前列腺剜除术(HoLEP)的学习曲线:一项系统评价
Urology. 2018 Oct;120:9-22. doi: 10.1016/j.urology.2018.06.012. Epub 2018 Jul 4.
7
Holmium laser enucleation of the prostate (HoLEP) for small, large and giant prostatic hyperplasia: tips and tricks.钬激光前列腺剜除术(HoLEP)治疗小体积、大体积及巨大前列腺增生:技巧与窍门
Urologia. 2017 Aug 1;84(3):169-173. doi: 10.5301/uj.5000232. Epub 2017 May 10.
8
Functional outcomes and complications following B-TURP versus HoLEP for the treatment of benign prostatic hyperplasia: a review of the literature and Meta-analysis.经尿道前列腺电切术(B-TURP)与钬激光前列腺剜除术(HoLEP)治疗良性前列腺增生后的功能结局及并发症:文献综述与Meta分析
Aging Male. 2017 Sep;20(3):184-191. doi: 10.1080/13685538.2017.1295436. Epub 2017 Apr 3.
9
Bipolar versus monopolar resection of benign prostate hyperplasia: a comparison of plasma electrolytes, hemoglobin and TUR syndrome.双极与单极前列腺良性增生切除术:血浆电解质、血红蛋白及经尿道前列腺电切综合征的比较
Springerplus. 2016 Oct 7;5(1):1739. doi: 10.1186/s40064-016-3407-7. eCollection 2016.
10
The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates.与下尿路症状相关的良性前列腺增生症的流行病学:患病率和发病率
Urol Clin North Am. 2016 Aug;43(3):289-97. doi: 10.1016/j.ucl.2016.04.001.